RDY introduces Levocetirizine tablets in the U.S. market
Links shared publicly online about this topic.
- 407total visits
RDY introduces Levocetirizine tablets in the U.S. market
Dr. Reddy's Laboratories has launched Levocetirizine tablets, a bioequivalent generic version of Xyzal tablets in the US market. The United States Food & Drug Administration approved Dr. Reddy's ANDA for Levocetirizine tablets on February 24, 2011.
View full resource at news-medical.net
Tags: Allergy Medication, Antihistamine, Diet and Nutrition, Drug, Xyzal
Most Recently Shared on March 28, 2011 at 11:12 am By:
RDY introduces Levocetirizine tablets in the U.S. market: Dr. Reddy's Laboratories has launched Levocetirizine t... http://bit.ly/gw44bN
Advertisement
